Percutaneous drainage can prevent the need for surgery in up to 30% of selected CD patients with the use of anti-tumor necrosis factor agents being associated with the higher success of conservative management [13], once sepsis had resolved [14], but our study cannot provide guidance on the outcomes of patient who did not require surgery following drainage, as these have not been captured. The gene discussed is TNF; the disease is Sepsis.